Ken Buck actually said...
But if new market entrants aren't able to submit an application and get it through the FDA, then guess what? You have, in this case, Mylan, who is able to market a product, quickly raise the price, bring home an exorbitant amount of profit, with no competition.
Context
Buck discusses the lack of competition in the pharmaceutical market leading to high prices.
09/20/2016